The latest price target for Chimerix (NASDAQ:CMRX) was reported by HC Wainwright & Co. on December 30, 2024. The analyst firm set a price target for $11.00 expecting CMRX to rise to within 12 months (a possible 225.60% upside). 6 analyst firms have reported ratings in the last year.

The latest analyst rating for Chimerix (NASDAQ:CMRX) was provided by HC Wainwright & Co., and Chimerix reiterated their buy rating.

There is no last upgrade for Chimerix

There is no last downgrade for Chimerix.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Chimerix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Chimerix was filed on December 30, 2024 so you should expect the next rating to be made available sometime around December 30, 2025.

While ratings are subjective and will change, the latest Chimerix (CMRX) rating was a reiterated with a price target of $11.00 to $11.00. The current price Chimerix (CMRX) is trading at is $3.38, which is out of the analyst’s predicted range.